Vaxart (OTC:VXRT) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.01) by 300 percent. This is a 128.57 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $39.227 million which missed the analyst consensus estimate of $65.500 million by 40.11 percent. This is a 87.90 percent increase over sales of $20.876 million the same period last year.